Sinomenine hydrochloride inhibits breast cancer metastasis by attenuating inflammation-related epithelial-mesenchymal transition and cancer stemness.
This study, together with our previous one, provides more evidence of SH as a potential drug for breast cancer therapy.
PMID: 28088791 [PubMed - as supplied by publisher]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Epithelial Cancer | Stem Cell Therapy | Stem Cells | Study | Toxicology